Studies have shown that, in pancreatic ductal adenocarcinoma, phosphorylation mediated by Polo-like kinase 1 (Plk1) can inhibit the nuclear translocation of NF-κB, thereby reducing PD-L1 expression (11). Here, PLK1 is linked to pancreatic ductal adenocarcinoma.